Co-Diagnostics, Inc. (CODX) stock

CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$0.28−0.01 (-3.78%)

Close on Nov 11, 2026Market cap $1.74MP/E –Yield –

Co-Diagnostics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Co-Diagnostics's pe ratio was 6.9× on Jan 31, 2023, against 5.0× a year earlier. Over the last 3 years it ranged from 3.6× to 53.2×, with a median of 5.8×.

PE Ratio at the end of each year

Period	Period end	Value	Change (pts)
2023	Jan 31, 2023	6.9×	+1.5
2022	Dec 30, 2022	5.4×	−1.0
2021	Dec 31, 2021	6.3×	−4.2
2020	Dec 31, 2020	10.5×	–

Where these numbers come from

Parsed from the XBRL in Co-Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on Jan 2, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing